Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter

View through CrossRef
Abstract Facioscapulohumeral dystrophy (FSHD) has a hypomethylation‐related epigenetic background and exhibits a different course in male and female patients. The differences between males and females have been linked to the levels of sex hormones. This study is the first to investigate the possible effect of these hormones on methylation status. We hypothesized that the levels of sex‐related hormones, estradiol, testosterone, progesterone, and prolactin might be associated with the methylation status of the proximal part of the D4Z4. We also investigated the effect of fT3, folic acid, and vitamin B12 levels. We collected blood from 28 FSHD patients and 28 controls. DNA was extracted from each individual for bisulfite methylation analysis and serum was separated for biochemical analysis of estradiol, testosterone, progesterone, prolactin, fT3, folic acid, and B12 analysis. Methylation analysis was specified to the DR1, 5P regions and the proximal region covering both DR1 and 5P. Methylation levels were compared between FSHD patients and controls. The correlation of methylation levels with estradiol, testosterone, progesterone, prolactin, fT3, folic acid, and B12 was investigated. We found that the 5P region and the proximal region were significantly hypomethylated in FSHD patients compared to the controls, but not the DR1 region. Male patients exhibited a significant reduction in DNA methylation compared to male controls. Older FSHD patients exhibited a notable decrease in fT3 levels and hypomethylation of the 5P region. Analyses of each CpG revealed seven hypomethylated positions that were significantly different from the control group. Two of the positions demonstrated a correlation with progesterone in the control group. With the exception of one position, the methylation levels were inversely correlated with vitamin B12 in FSHD patients. The results of our study indicate that the methylation of the proximal D4Z4 region, particularly at specific positions, may be associated with progesterone. In addition, vitamin B12 may be an indicator of hypomethylation. We suggest that examining position‐specific methylations may be a useful approach for the development of epigenetic treatment modalities. image
Title: Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter
Description:
Abstract Facioscapulohumeral dystrophy (FSHD) has a hypomethylation‐related epigenetic background and exhibits a different course in male and female patients.
The differences between males and females have been linked to the levels of sex hormones.
This study is the first to investigate the possible effect of these hormones on methylation status.
We hypothesized that the levels of sex‐related hormones, estradiol, testosterone, progesterone, and prolactin might be associated with the methylation status of the proximal part of the D4Z4.
We also investigated the effect of fT3, folic acid, and vitamin B12 levels.
We collected blood from 28 FSHD patients and 28 controls.
DNA was extracted from each individual for bisulfite methylation analysis and serum was separated for biochemical analysis of estradiol, testosterone, progesterone, prolactin, fT3, folic acid, and B12 analysis.
Methylation analysis was specified to the DR1, 5P regions and the proximal region covering both DR1 and 5P.
Methylation levels were compared between FSHD patients and controls.
The correlation of methylation levels with estradiol, testosterone, progesterone, prolactin, fT3, folic acid, and B12 was investigated.
We found that the 5P region and the proximal region were significantly hypomethylated in FSHD patients compared to the controls, but not the DR1 region.
Male patients exhibited a significant reduction in DNA methylation compared to male controls.
Older FSHD patients exhibited a notable decrease in fT3 levels and hypomethylation of the 5P region.
Analyses of each CpG revealed seven hypomethylated positions that were significantly different from the control group.
Two of the positions demonstrated a correlation with progesterone in the control group.
With the exception of one position, the methylation levels were inversely correlated with vitamin B12 in FSHD patients.
The results of our study indicate that the methylation of the proximal D4Z4 region, particularly at specific positions, may be associated with progesterone.
In addition, vitamin B12 may be an indicator of hypomethylation.
We suggest that examining position‐specific methylations may be a useful approach for the development of epigenetic treatment modalities.
image.

Related Results

Characterization of B12 Deficiency in Patients with Plasma Cell Disorders
Characterization of B12 Deficiency in Patients with Plasma Cell Disorders
Abstract Background: Although vitamin B12 deficiency has been reported in patients with plasma cell dyscrasias (PCDs), no mechanism has been identifie...
Age at onset mediates genetic impact on disease severity in facioscapulohumeral muscular dystrophy
Age at onset mediates genetic impact on disease severity in facioscapulohumeral muscular dystrophy
Abstract Facioscapulohumeral muscular dystrophy type 1 (FSHD1) patients exhibit marked variability in both age at onset (AAO) and disease severity. Early onset FSHD1...
Does DNA Methylation Matter in FSHD?
Does DNA Methylation Matter in FSHD?
Facioscapulohumeral muscular dystrophy (FSHD) has been associated with the genetic and epigenetic molecular features of the CpG-rich D4Z4 repeat tandem array at 4q35. Reduced DNA m...
Elevated Plasma Vitamin B12 in Patients with Hepatic Glycogen Storage Diseases
Elevated Plasma Vitamin B12 in Patients with Hepatic Glycogen Storage Diseases
Background: Hepatic glycogen storage diseases (GSDs) are inborn errors of metabolism affecting the synthesis or breakdown of glycogen in the liver. This study, for the first time, ...
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Background: Metformin is the most commonly used drug for patients with type 2 diabetes mellitus (T2DM) patients. Metformin related vitamin B12 deficiency can cause anemia. Accordin...
Vitamin B12 Replasman Tedavisi; Oral? İntramüsküler?
Vitamin B12 Replasman Tedavisi; Oral? İntramüsküler?
Amaç: Bu çalışmanın amacı intramüsküler B12 replasman tedavisi ile oral B12 replasman tedavisinin kan B12 vitamini düzeyleri üzerine olan etkisinin karşılaştırılmasıdır.Materyal ve...
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract Cholangiocarcinoma (CCA) is a malignancy of bile duct epithelial cell lining. In the past decade, the incidence and mortality rates of CCA have been increas...

Back to Top